IL17A and metabolic dysfunction-associated steatotic liver disease: This also directly proves that metabolic disorders caused by IBD can cause NAFLD, affect the secretion regulation of IL-17 and chemokines, and may further cause intestinal inflammation and damage through IL-17-related pathways (Supplementary Figure 2).